Nanotechnology-enabled precision strategies for bladder cancer: from in vitro diagnostics to in vivo therapy
Kaiwen Xiao, Bailing Zhou, Dechao Feng, Shangsong Yang, Sibei Lei, Dilinaer Wusiman, Zhixuan Jiang, Fei Li, Mohan Liu · 2026
Read Nanotechnology-enabled precision strategies for bladder cancer: from in vitro diagnostics to in vivo therapy by Kaiwen Xiao, Bailing Zhou, Dechao Feng, Shangsong Yang, Sibei Lei, Dilinaer Wusiman, Zhixuan Jiang, Fei Li, Mohan Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13491625.txt.
Description
Kaiwen Xiao and eight co-authors survey in 2026 how nanotechnology could sharpen both diagnosis and treatment of bladder cancer. The disease returns often, resists therapy, and lacks tools that detect and treat it in one system. Their review ties material design choices, such as particle size and surface chemistry, to performance inside the bladder's unusual environment.
Nano-sized sensors can pick up faint urinary biomarkers and support liquid biopsy, while engineered carriers hold drugs against the bladder wall despite constant urine flow. Platforms that merge imaging with therapy promise feedback during treatment rather than after it. The authors also weigh safety, reproducibility, and manufacturing scale, and they point toward artificial intelligence helping design future materials.
Catalog record
| CREATOR | Kaiwen Xiao, Bailing Zhou, Dechao Feng, Shangsong Yang, Sibei Lei, Dilinaer Wusiman, Zhixuan Jiang, Fei Li, Mohan Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 145650 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |